Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation.

Chang ML, Yeh CT, Lin DY, Ho YP, Hsu CM, Bissell DM.

BMC Med Genomics. 2009 Aug 8;2:51. doi: 10.1186/1755-8794-2-51.

2.

Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis.

Koike K, Tsutsumi T, Miyoshi H, Shinzawa S, Shintani Y, Fujie H, Yotsuyanagi H, Moriya K.

J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S87-91. doi: 10.1111/j.1440-1746.2007.05292.x.

PMID:
18336672
3.

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.

Bernsmeier C, Duong FH, Christen V, Pugnale P, Negro F, Terracciano L, Heim MH.

J Hepatol. 2008 Sep;49(3):429-40. doi: 10.1016/j.jhep.2008.04.007.

PMID:
18486982
4.

Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.

Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT.

Hepatology. 2005 Mar;41(3):660-7.

PMID:
15723444
5.

Hepatitis C virus core protein, lipid droplets and steatosis.

Roingeard P, Hourioux C.

J Viral Hepat. 2008 Mar;15(3):157-64. Review.

PMID:
18086178
6.

Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice.

Wang AG, Lee DS, Moon HB, Kim JM, Cho KH, Choi SH, Ha HL, Han YH, Kim DG, Hwang SB, Yu DY.

J Pathol. 2009 Oct;219(2):253-62. doi: 10.1002/path.2592.

PMID:
19621337
7.

Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver.

Mori Y, Moriishi K, Matsuura Y.

Int J Biochem Cell Biol. 2008;40(8):1437-42. doi: 10.1016/j.biocel.2008.01.027. Review.

PMID:
18321762
8.

HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration.

Chang ML, Yeh HC, Tsou YK, Wang CJ, Cheng HY, Sung CM, Ho YP, Chen TH, Yeh CT.

Obesity (Silver Spring). 2012 Jul;20(7):1474-80. doi: 10.1038/oby.2012.45.

9.

[Establishment of a tight tetracycline-controlled HCV-C double transgenic mouse model].

Shuai LF, Tang BH, Zhang RS, Zhao Y, Yang GZ, Cheng XG.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(9):1530-3. Chinese.

10.

Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.

Negro F, Sanyal AJ.

Liver Int. 2009 Mar;29 Suppl 2:26-37. doi: 10.1111/j.1478-3231.2008.01950.x. Review.

PMID:
19187070
11.

Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.

Tiftikci A, Atug O, Yilmaz Y, Eren F, Ozdemir FT, Yapali S, Ozdogan O, Celikel CA, Imeryuz N, Tozun N.

Arch Med Res. 2009 May;40(4):294-8. doi: 10.1016/j.arcmed.2009.04.008.

PMID:
19608019
12.

Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R.

J Immunol. 2016 Aug 15;197(4):1127-36. doi: 10.4049/jimmunol.1600631.

PMID:
27357152
13.

Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice.

Chang ML, Chen JC, Yeh CT, Sheen IS, Tai DI, Chang MY, Chiu CT, Lin DY, Bissell DM.

World J Gastroenterol. 2007 Jul 7;13(25):3472-7.

14.

Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Diamond MS, Atkinson JP, Ray R.

J Virol. 2013 Jul;87(14):7902-10. doi: 10.1128/JVI.00917-13.

15.

Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model.

Perlemuter G, Lettéron P, Carnot F, Zavala F, Pessayre D, Nalpas B, Bréchot C.

J Hepatol. 2003 Dec;39(6):1020-7.

PMID:
14642621
16.

Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis.

Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, Sheen IS, Tai DI, Chu CM, Lin WP, Chang MY, Liang CK, Chiu CT, Lin DY.

BMC Genomics. 2008 Feb 29;9:109. doi: 10.1186/1471-2164-9-109.

17.

Correlation of steatosis with fibrosis and necro-inflammation in chronic hepatitis C infection in the absence of confounding factors.

Zubair A, Mubarik A, Jamal S, Arif A, Khan DA.

J Coll Physicians Surg Pak. 2009 Jul;19(7):417-20. doi: 07.2009/JCPSP.417420.

PMID:
19576148
18.

A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.

He S, Atkinson C, Qiao F, Cianflone K, Chen X, Tomlinson S.

J Clin Invest. 2009 Aug;119(8):2304-16. doi: 10.1172/JCI38289.

19.

Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells.

Moriya K, Miyoshi H, Tsutsumi T, Shinzawa S, Fujie H, Shintani Y, Yotsuyanagi H, Moriishi K, Matsuura Y, Suzuki T, Miyamura T, Koike K.

Am J Pathol. 2009 Oct;175(4):1515-24. doi: 10.2353/ajpath.2009.090102.

20.

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K.

J Gen Virol. 1997 Jul;78 ( Pt 7):1527-31.

PMID:
9225025
Items per page

Supplemental Content

Support Center